Aligos Therapeutics, Inc.
ALGS
$7.22
-$0.43-5.62%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 54.91M | 77.84M | 99.10M | 122.95M | 137.86M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 4.72M | 5.02M | 4.34M | 5.00M | 5.34M |
| Total Current Assets | 59.63M | 82.86M | 103.44M | 127.94M | 143.21M |
|
|
|||||
| Total Current Assets | 59.63M | 82.86M | 103.44M | 127.94M | 143.21M |
| Net Property, Plant & Equipment | 4.17M | 4.96M | 5.62M | 6.12M | 6.86M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 759.00K | 715.00K | 713.00K | 640.00K | 632.00K |
| Total Assets | 64.56M | 88.53M | 109.76M | 134.71M | 150.70M |
|
|
|||||
| Total Accounts Payable | 7.64M | 3.98M | 4.65M | 3.94M | 4.46M |
| Total Accrued Expenses | 11.99M | 13.53M | 13.61M | 12.21M | 11.00M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.69M | 3.73M | 3.56M | 3.54M | 3.49M |
| Total Finance Division Other Current Liabilities | -- | -- | 168.00K | 579.00K | -- |
| Total Other Current Liabilities | -- | -- | 168.00K | 579.00K | -- |
| Total Current Liabilities | 23.32M | 21.23M | 21.99M | 20.27M | 18.95M |
|
|
|||||
| Total Current Liabilities | 23.32M | 21.23M | 21.99M | 20.27M | 18.95M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 659.00K | 1.53M | 2.50M | 3.34M | 4.39M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 8.79M | 12.23M | 13.44M | 9.24M | 10.92M |
| Total Liabilities | 32.77M | 34.99M | 37.93M | 32.84M | 34.25M |
|
|
|||||
| Common Stock & APIC | 696.59M | 695.28M | 693.70M | 692.23M | 690.92M |
| Retained Earnings | -665.24M | -642.20M | -622.32M | -590.78M | -574.92M |
| Treasury Stock & Other | 438.00K | 468.00K | 455.00K | 420.00K | 447.00K |
| Total Common Equity | 31.79M | 53.55M | 71.83M | 101.87M | 116.45M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 31.79M | 53.55M | 71.83M | 101.87M | 116.45M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 31.79M | 53.55M | 71.83M | 101.87M | 116.45M |
|
|
|||||